ImmunologybioRxivPreprint
PVRL2 Suppresses Anti-tumor Immunity Through PVRIG- and TIGIT-Independent Pathways
J. Yang, L. Wang, J. R. Byrnes…·R. Blelloch
This study shows PVRL2 suppresses anti-tumor immunity independently of PVRIG and TIGIT, with deletion reducing tumor growth more than PD-L1 loss.
DOI 10.1101/2024.01.26.577132